Related Experiment Video
Updated: Apr 7, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker
Shuo Zeng1, Yu-Feng Xiao1, Bo Tang1
1Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Abstract:
Digestive tract cancers (DTCs) are a leading cause of cancer-related death worldwide. Current therapeutic tools for advanced stage DTCs have limitations, and patients with early stage DTCs frequently have a missed diagnosis due to shortage of efficient biomarkers. Consequently, it is necessary to develop novel biomarkers for early diagnosis and novel therapeutic targets for treatment of DTCs. In recent years, long noncoding RNAs (lncRNAs), a class of noncoding RNAs with >200 nucleotides, have been shown to be aberrantly expressed in DTCs and to have an important role in DTC development: the expression profiles of lncRNAs strongly correlated with poor survival of patients with DTCs, and lncRNAs acted as oncogenes or tumor suppressor genes in DTC progression. In this review, we summarized the functional lncRNAs and expounded on their regulatory mechanisms in DTCs.
Insights
Long noncoding RNAs (lncRNAs) show abnormal expression in digestive tract cancers (DTCs), impacting patient survival. Understanding lncRNA functions and mechanisms is crucial for developing new diagnostic biomarkers and therapeutic targets for DTCs.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Digestive tract cancers (DTCs) are a major global cause of cancer mortality.
- Current treatments for advanced DTCs are limited, and early diagnosis is hindered by a lack of effective biomarkers.
- There is a critical need for novel biomarkers for early detection and new therapeutic targets for DTCs.
Purpose of the Study:
- To review the role of long noncoding RNAs (lncRNAs) in the development and progression of digestive tract cancers.
- To summarize the functions and regulatory mechanisms of lncRNAs implicated in DTCs.
- To highlight the potential of lncRNAs as diagnostic biomarkers and therapeutic targets for DTCs.
Main Methods:
- Literature review focusing on studies investigating lncRNAs in digestive tract cancers.
- Analysis of research on the aberrant expression of lncRNAs in DTCs.
- Examination of the oncogenic and tumor-suppressive roles of lncRNAs in DTC progression.
Main Results:
- lncRNAs are frequently aberrantly expressed in DTCs.
- lncRNA expression profiles correlate with poor patient survival in DTCs.
- lncRNAs function as either oncogenes or tumor suppressor genes in DTCs.
Conclusions:
- lncRNAs play significant roles in the pathogenesis of digestive tract cancers.
- lncRNAs represent promising candidates for early diagnostic biomarkers and therapeutic targets in DTCs.
- Further research into lncRNA regulatory mechanisms is warranted for advancing DTC treatment strategies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...